How Clinical and Personal Information Shape Physicians' Risk Judgments
NCT ID: NCT07162376
Last Updated: 2026-01-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
300 participants
INTERVENTIONAL
2025-09-16
2025-09-26
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
To form judgments of risk, physicians should attend to a host of validated factors that are predictive of disease. However, research suggests that physicians may rely on demographic factors-such as race and gender. Physicians' judgments could also be influenced by non-health-related, personal information about their patients (e.g., hobbies, nicknames), which may moderate the impact of demographics on those judgments.
The investigators examine these dynamics in the context of heart disease. The History, Electrocardiogram, Age, Risk factors and Troponin (HEART) Score is a validated model that specifies a correspondence between certain risk factors and the likelihood of Major Adverse Cardiac Event (MACE). Importantly, there are substantially different diagnostic tests (e.g., noninvasive stress test versus coronary angiogram) that should be used depending on a patient's MACE likelihood.
Specifically, the investigators have three research questions:
* Research Question 1 (RQ1): How accurate are physicians relative to the benchmarks from the HEART score model?
* Research Question 2 (RQ2): How do clinically-relevant risk factors (e.g., smoking history), race, gender, and personal information disclosure influence risk judgments?
* Research Question 3 (RQ3): Does personal information disclosure moderate the effects of race and gender on risk judgments?
Note that when the investigators discuss accuracy and error, they are referring to the comparison of physician judgments to the HEART score model benchmarks.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Level of Concordance Between Patients Perception and Physicians Evaluation of Cardiovascular Risk
NCT01781416
The Psychosocial Effect of Thoughts of Personal Mortality on Cardiac Risk Assessment by Medical Students
NCT00500136
Human Factors Intervention to Reduce Risk in Primary Care of the Elderly
NCT01326637
Physician Awareness of Patients' Preferred Level of Involvement in Decision Making
NCT05314959
Disclosure of Industry Payments to Physicians and the Patient-Doctor Relationship
NCT02179632
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
To do this, the investigators designed a mixed-design experiment. Each participant will respond to eight patient profiles that vary along three fully-crossed within-subject factors: (i) race: black vs. white, (ii) gender: man vs. woman, and (iii) risk factors: low vs. medium risk (based on risk levels from the HEART score model). Each participant will also be randomly assigned (between-subjects) to (iv) either see non-health-related personal information (e.g., hobbies) for all eight of their patients, or not see this information for any of their patients. The investigators refer to each factor as a profile attribute.
For each profile, participants indicate the perceived risk of a major adverse cardiac event in the six weeks following the visit. Our primary outcome is a measure of absolute error in perceived risk of MACE (described under the Primary Outcome section). They also indicate the diagnostic test they believe is most appropriate (Secondary Outcome #4).
Analysis plan
For all analyses, the investigators will format the data such that there are eight observations per participant, each corresponding to a patient profile the participant responded to.
* To test RQ1, the investigators will estimate an Ordinary Least Squares (OLS) regression predicting the primary outcome. The investigators will cluster standard errors by physician. The constant reflects the mean of our primary outcome, reflecting the extent to which physicians are inaccurate.
* To test RQ2, the investigators will estimate an OLS regression predicting the primary outcome. The independent variables include four indicators to model the profile attributes: an indicator for risk factors, an indicator for gender, an indicator for race, and an indicator for personal information disclosure. The model will also include fixed effects for physician specialty (emergency medicine, cardiologists, and hospitalists). The investigators will cluster standard errors by physician.
* To test RQ3, the investigators will reestimate the primary model testing RQ2 twice: In one model, the investigators will add an interaction term between personal information disclosure and race; and in the second model, the investigators will add an interaction term between personal information disclosure and gender.
As secondary analyses,
* The investigators will estimate the models above except using Secondary Outcomes Measures #1-3
* The investigators will measure participants' choice of appropriate diagnostic test for each patient as a secondary outcome (see Secondary Outcome #4). The investigators will estimate a multinomial logistic regression predicting choice of appropriate diagnostic test as the categorical outcome (with "routine follow-up" as the reference category). The independent variables include the four profile attribute indicators and physician specialty fixed effects. The investigators will cluster standard errors by physician.
* The investigators will reestimate the primary models testing RQ2, except including pairwise interactions between the physician specialty fixed effects and each of the four attributes.
* The investigators will reestimate the primary model testing RQ2, except adding all pairwise interactions between the four attributes as independent variables.
* The investigators will measure overconfidence (see Secondary Outcome Measure #5). With data at the physician-level, the investigators will estimate an OLS regression predicting overconfidence. The investigators will reestimate the model, except adding the two indicators for physician specialty and the indicator for personal information disclosure as independent variables.
The investigators will also measure and explore (i) qualitative open-ended responses about how they made their risk estimations, (ii) whether participants use the HEART score model at their jobs (or another model), (iii) if they use a model, why they use it, (iv) if they have heard of the HEART score model, (v) if they looked up anything while taking the study, and (vi) if yes, what they looked up.
The investigators plan to recruit 300 physicians using the Medscape panel.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
No Personal Information Disclosure
Participants rate 8 patient profiles of patients with chest pain. The profiles each contain info about the patient's race, gender, and risk factors associated with MACE.
No interventions assigned to this group
Personal Information Disclosure
Participants rate 8 patient profiles of patients with chest pain. The profiles each contain info about the patient's race, gender, and risk factors associated with MACE. Each profile also contains non-health related personal information that the patient has disclosed (e.g., nickname, hobbies).
Personal Information Disclosure
Each profile also contains non-health related personal information that the patient has disclosed (e.g., nickname, hobbies).
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Personal Information Disclosure
Each profile also contains non-health related personal information that the patient has disclosed (e.g., nickname, hobbies).
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Cardiologists
* Hospitalists (i.e., internists whose practice is primarily in the hospital)
* If there are duplicate participant IDs in the data, only the first response will be included in the analysis
Exclusion Criteria
* Participants who write gibberish in the open-ended items
* Incomplete responses
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Maryland, College Park
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Joseph Reiff
Assistant Professor of Marketing
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Joseph Reiff, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Maryland Robert H. Smith School of Business
Aneesh Rai, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Maryland Robert H. Smith School of Business
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Van Munching Hall
College Park, Maryland, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2281657-2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.